The focus of our work is the study and investigation of pathogens which are medically relevant or can be used as models for researching infection mechanisms.
To the research topics
Around 700 employees in research, administration and infrastructure, and about 140 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research.
Our scientists pursue research to expand our knowledge of the fundamental mechanisms behind medically relevant infectious diseases.
To the open positions
World Class research demands concentrated and focused support. To be internationally successful, adequate financial resources and a supportive environment are both important. This applies also to the Helmholtz Centre for Infection Research (HZI).
The Friends of the Helmholtz-Centre for Infection Research made it their business to support important activities of the centre. This concerns among others the results of basic research that is developed further to medical application.
How pathogens make us sick – and how our immune system fights them
HZI researchers are studying the tricks of bacteria and viruses
The search for better and safer antiinfectives
The HZI is turning 50! All information on the anniversary can be found here.
Certain proteins play a crucial role in the processing of genetic information by bacteria: The so-called sigma factors are responsible for the start of transcription, i.e. the process of making RNA from DNA. Recently, Scientists of the Helmholtz Centre for Infection Research (HZI) in Braunschweig were the first to describe the group of genes regulated by the most important sigma factors...
Treating respiratory disease is often difficult because drugs have to cross biological barriers such as respiratory tissue and mucosa, and must therefore be given in large quantities in order for an effective amount to reach the target. Now researchers from Germany, Brazil and France have shown that the use of nanoparticles to carry antibiotics across biological barriers can be effective...
Traditional antibiotics work by suppressing the growth of pathogens. This is necessarily associated with the development of resistance. Scientists of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) recently discovered a group of substances that utilise a new mechanism of action: They block the bacterial communication pathways. As a result, the pathogens can no longer...
How do bacterial pathogens gain entry into our cells and how do they make us ill? Those are the questions that will be investigated by the biochemist Michael Kolbe at the Centre for Structural Systems Biology (CSSB) in Hamburg starting from February 2015. He and his team are going to study the molecular mechanisms used by gram-negative bacteria, such as Shigella or Salmonella, to...
The IKBNS protein is very important for the development of immune cells: Two years ago, it was discovered that regulatory T cells, so-called Tregs, do not develop in the absence of this protein. The IKBNS protein also plays a role in the development of another type of cell, i.e. Th 17 cells. Scientists working at the Helmholtz Centre for Infection Research (HZI) in Braunschweig have...
9 April 2015, 7 pm
HZI, Inhoffenstraße 7, Braunschweig
Helmholtz Centre for Infection ResearchInhoffenstraße 738124 Braunschweig+49 531 firstname.lastname@example.org
Helmholtz Institute for Pharmaceutical Research SaarlandCampus, Geb. C2.3Universität des Saarlandes66123 Saarbrücken+49 681 email@example.com
TWINCOREZentrum für Experimentelle und Klinische InfektionsforschungFeodor-Lynen-Str. 730625 Hannover+49 511 firstname.lastname@example.org
Study Centre HannoverFeodor-Lynen-Straße 1530625 Hannover+49 511 5350 email@example.com